12 news items
KORU Medical Systems Signs Supply Agreement For Phase III Clinical Trial For A Novel Enzyme Replacement Therapy To Treat A Rare Endocrinological Disease
KRMD
14 May 24
KORU Medical Systems Q1 2024 Adj EPS $(0.02) Beats $(0.04) Estimate, Sales $8.198M Beat $7.467M Estimate
KRMD
1 May 24
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth
KRMD
1 May 24
KORU Medical Systems Announces Successful Appeal In EU Notified Body Review
KRMD
11 Apr 24
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
KRMD
11 Apr 24
8scvyw27hy 1edmf72ikb3296v
KRMD
14 Mar 24
5rrt2zq8plgyd8mw4b858w7 76wgma6o71
KRMD
13 Mar 24
txyyn164qim4dao y1m
KRMD
13 Mar 24
8bfta
AADI
ACDC
ADCT
13 Mar 24
0t1w0pv4bckqw2 od394z3ih8sq9j520dshzce5k91pez
KRMD
12 Mar 24
llp811h7f
KRMD
6 Mar 24
c0483zb2l1jt8ciu5jdckn ci1tx27z7my2uslemsqh2frkungf
KRMD
6 Mar 24
- Prev
- 1
- Next